McKesson's adjusted EPS tops estimates in Q3 CY2026 and guidance is raised
FROM THE WIRE · FINANCE.YAHOO.COM
McKesson's (NYSE:MCK) Q3 CY2026 adjusted EPS top estimates Healthcare distributor and services company McKesson (NYSE:MCK) beat Wall Street's revenue expectations in calendar Q3 2026 (fiscal Q2 2027), with revenue up 7.6% year on year to $111 billion. Its non-GAAP profit of…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishEarnings above expectations and a raised guidance for a large healthcare distributor, with moderate stock impact.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Adjusted EPS was $11.68, above the consensus of $10.75.
- 02Revenue rose 7.6% year on year to $111 billion.
- 03Full-year adjusted EPS guidance was raised to $46 at the midpoint.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets